Béatrice Pangon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Béatrice Pangon has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- P. Y. Allouch
Service d'hygiène hospitalière, hôpital A.-Mignot, 177, route de Versailles, 78150 Le Chesnay, France
10 shared publications P Pina
6 shared publicationsJ C Ghnassia
4 shared publications- Odile Eloy
Service de microbiologie, Hôpital André-Mignot, 177, rue de Versailles, 78157 Le Chesnay
3 shared publications C Chaplain
2 shared publicationsJ P Bedos
2 shared publications
Latest Publications
- 1 February 2018
- Published by Elsevier in Journal of Critical Care
- Vol. 43, 375-377
Prior antimicrobial therapy duration influences causative pathogens identification in ventilator-associated pneumonia
- 1 February 2018
- Published by Elsevier in Journal of Critical Care
- Vol. 43, 375-377
Prior antimicrobial therapy duration influences causative pathogens identification in ventilator-associated pneumonia
- 1 October 2006
- p. S44-7
[Pseudomonas aeruginosa and cystic fibrosis: non-antibiotic strategy].
The Pseudomonas aeruginosa bronchopulmonary infection is, when chronical, a poor prognosis factor for cystic fibrosis children. The higher life expectancy is partly linked to the progresses of the antipseudomonal antibiotherapy: treatment modulated to the stage of infection; possible use of nebulized and oral (ciprofloxacin) antibiotics. But the antipseudomonal strategy does not limit to the antibiotherapy. The preventive approach includes: preservation of a good nutritional status; daily chest physiotherapy with combined use of aerosolized recombinant human DNase for more than 5 years old children with significative bronchorrea; early anti-infammatory treatment with inhaled corticosteroids, despite a poor efficacy proof level; hygiene measures to reduce the environmental and domestic reservoirs and to avoid nosocomial infections. The development of vaccines for the prevention of P. aeruginosa infection is a promising way but stays in the field of clinical research. In case of chronical infection, long-term macrolids reduce the virulence factors expression of the bacteria, leading to antibiofilm properties in spite of subinhibitory concentrations.
- 1 October 2006
- p. S44-7
[Pseudomonas aeruginosa and cystic fibrosis: non-antibiotic strategy].
The Pseudomonas aeruginosa bronchopulmonary infection is, when chronical, a poor prognosis factor for cystic fibrosis children. The higher life expectancy is partly linked to the progresses of the antipseudomonal antibiotherapy: treatment modulated to the stage of infection; possible use of nebulized and oral (ciprofloxacin) antibiotics. But the antipseudomonal strategy does not limit to the antibiotherapy. The preventive approach includes: preservation of a good nutritional status; daily chest physiotherapy with combined use of aerosolized recombinant human DNase for more than 5 years old children with significative bronchorrea; early anti-infammatory treatment with inhaled corticosteroids, despite a poor efficacy proof level; hygiene measures to reduce the environmental and domestic reservoirs and to avoid nosocomial infections. The development of vaccines for the prevention of P. aeruginosa infection is a promising way but stays in the field of clinical research. In case of chronical infection, long-term macrolids reduce the virulence factors expression of the bacteria, leading to antibiofilm properties in spite of subinhibitory concentrations.
- 31 October 2003
- Published by Elsevier in Pathologie Biologie
- Vol. 51 (8-9) , 503-507
Pyélonéphrite aiguë : bactériologie et évolution des résistances
- 31 October 2003
- Published by Elsevier in Pathologie Biologie
- Vol. 51 (8-9) , 503-507
Pyélonéphrite aiguë : bactériologie et évolution des résistances
- 26 November 2002
- Vol. 60 (6) , 711-4
[Detection of circulating Candida albicans mannan and antimannan antibodies: useful for diagnosis of deep seated candidiasis].
In deep seated candidiasis, only 40% of blood cultures are positive. The aim of the study was to investigate circulating Candida albicans mannan and anti-mannan antibodies as a possible help for the diagnosis of deep seated candidiasis. We have compared the results to the detection of IgM by Elisa and antibodies by immunoflourescence. The best tests, in accord to their sensitivity and specificity, are the mannan antigenemia (43% and 100%) and IgM (86% and 100%) and have to be used together.
- 26 November 2002
- Vol. 60 (6) , 711-4
[Detection of circulating Candida albicans mannan and antimannan antibodies: useful for diagnosis of deep seated candidiasis].
In deep seated candidiasis, only 40% of blood cultures are positive. The aim of the study was to investigate circulating Candida albicans mannan and anti-mannan antibodies as a possible help for the diagnosis of deep seated candidiasis. We have compared the results to the detection of IgM by Elisa and antibodies by immunoflourescence. The best tests, in accord to their sensitivity and specificity, are the mannan antigenemia (43% and 100%) and IgM (86% and 100%) and have to be used together.
- 15 February 2001
- Vol. 59 (1) , 79-83
[Value of the detection of anti-Candida antibodies and IgM isotypes in the diagnosis of deep Candida infections].
- 15 February 2001
- Vol. 59 (1) , 79-83
[Value of the detection of anti-Candida antibodies and IgM isotypes in the diagnosis of deep Candida infections].
- 1 October 2000
- Vol. 48 (8) , 792-5
In vitro activity of teicoplanin against gram-positive cocci.
The glycopeptide susceptibility of 443 clinical isolates of gram-positive cocci collected from nine general hospitals in 1996 was determined according to the recommendations of the CA-SFM (the Antibiogram Committee of the French Society for Microbiology). In total, 234 isolates of Staphylococcus aureus, 84 isolates of coagulase-negative staphylococci (CNS), 98 enterococci and 27 streptococci were collected. The mecA gene confirming resistance to methicillin was found in 42.7% of S. aureus isolates and 51.2% of CNS isolates. No resistance to teicoplanin and vancomycin was found in S. aureus but four isolates of CNS had an MIC of teicoplanin > or = 8 mg/L. All isolates of Enterococcus faecalis tested were susceptible to both glycopeptides. This study confirms that teicoplanin has a very good in vitro activity against gram-positive cocci, isolated in France from nosocomial infections.
- 1 October 2000
- Vol. 48 (8) , 792-5
In vitro activity of teicoplanin against gram-positive cocci.
The glycopeptide susceptibility of 443 clinical isolates of gram-positive cocci collected from nine general hospitals in 1996 was determined according to the recommendations of the CA-SFM (the Antibiogram Committee of the French Society for Microbiology). In total, 234 isolates of Staphylococcus aureus, 84 isolates of coagulase-negative staphylococci (CNS), 98 enterococci and 27 streptococci were collected. The mecA gene confirming resistance to methicillin was found in 42.7% of S. aureus isolates and 51.2% of CNS isolates. No resistance to teicoplanin and vancomycin was found in S. aureus but four isolates of CNS had an MIC of teicoplanin > or = 8 mg/L. All isolates of Enterococcus faecalis tested were susceptible to both glycopeptides. This study confirms that teicoplanin has a very good in vitro activity against gram-positive cocci, isolated in France from nosocomial infections.
- 1 June 2000
- Vol. 48 (5) , 485-9
[Antibiotic sensitivity of enterobacteria in intensive care units].
Antibiotic therapy of intensive care patients is usually undocumented. The treatment is chosen according to epidemiologic and susceptibility data from microbiological laboratories. The aim of our study is to determine antibiotic susceptibility of enterobacteria isolated from intensive care patients during a five-month multicenter study in 18 French hospitals. Numerous (n = 1,113) strains were studied: 447 enterobacteria isolated from urine (n = 229), blood cultures (n = 106), respiratory tract specimens (n = 72), peritoneal fluids (n = 22), pus (n = 15) and catheters (n = 2). MICs of group 2 and group 3 enterobacteria were determined using the dilution agar method and were interpreted according to the CASFM (Comité de l'antibiogramme de la société française de microbiology) recommendations. Group 1 enterobacteria were most frequently isolated (67%). Only one Escherichia coli strain produced ESBL (0.3%). Among group 2 enterobacteria, one Citrobacter koseri strain produced ESBL. We did not isolate Klebsiella pneumoniae ESBL. Isolation of group 3 enterobacteria was frequent (24%). Thirty-five percent of group 3 enterobacteria were resistant to cefotaxime, 26% to ceftazidime and 16% to cefepime and cefpirome. Fourteen strains of this group produced ESBL: 13 Enterobacter aerogenes and one E. amnigenus.
- 1 June 2000
- Vol. 48 (5) , 485-9
[Antibiotic sensitivity of enterobacteria in intensive care units].
Antibiotic therapy of intensive care patients is usually undocumented. The treatment is chosen according to epidemiologic and susceptibility data from microbiological laboratories. The aim of our study is to determine antibiotic susceptibility of enterobacteria isolated from intensive care patients during a five-month multicenter study in 18 French hospitals. Numerous (n = 1,113) strains were studied: 447 enterobacteria isolated from urine (n = 229), blood cultures (n = 106), respiratory tract specimens (n = 72), peritoneal fluids (n = 22), pus (n = 15) and catheters (n = 2). MICs of group 2 and group 3 enterobacteria were determined using the dilution agar method and were interpreted according to the CASFM (Comité de l'antibiogramme de la société française de microbiology) recommendations. Group 1 enterobacteria were most frequently isolated (67%). Only one Escherichia coli strain produced ESBL (0.3%). Among group 2 enterobacteria, one Citrobacter koseri strain produced ESBL. We did not isolate Klebsiella pneumoniae ESBL. Isolation of group 3 enterobacteria was frequent (24%). Thirty-five percent of group 3 enterobacteria were resistant to cefotaxime, 26% to ceftazidime and 16% to cefepime and cefpirome. Fourteen strains of this group produced ESBL: 13 Enterobacter aerogenes and one E. amnigenus.
- 2 December 1999
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 18 (11) , 836-838
Antimicrobial Susceptibility of 471 Enterococcal Strains Responsible for Infections at 101 French Hospitals
- 2 December 1999
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 18 (11) , 836-838
Antimicrobial Susceptibility of 471 Enterococcal Strains Responsible for Infections at 101 French Hospitals
- 1 May 1999
- Vol. 47 (5) , 474-7
Epidemiological study of Staphylococcus aureus resistant to methicillin responsible for nosocomial infections in nine French hospitals.
A number of European studies found that nosocomial infections were caused by a limited number of methicillin-resistant Staphylococcus aureus (MRSA) strains. A study was undertaken to determine the number of MRSA clones responsible for nosocomial infections in France. Strains responsible for nosocomial infections meeting CDC criteria were collected one week every month from June to October 1997 in nine French hospitals. Strains that were positive by the oxacillin-resistance screening test were studied for the IS 431, femA, and mecA genes. Strain type was identified using pulsed-field gel electrophoresis of fragments produced by Smal digestion. Susceptibility to antimicrobials was evaluated based on inhibition zone diameters and minimal inhibitory concentrations determined using the agar dilution method. The 83 strains studied were distributed across four pulsotypes. Eleven resistance phenotypes were identified by ascending hierarchical classification based on inhibition zone diameters. MRSAs responsible for nosocomial infections belong to a limited number of clones that express variable levels of resistance to antimicrobials.
- 1 May 1999
- Vol. 47 (5) , 474-7
Epidemiological study of Staphylococcus aureus resistant to methicillin responsible for nosocomial infections in nine French hospitals.
A number of European studies found that nosocomial infections were caused by a limited number of methicillin-resistant Staphylococcus aureus (MRSA) strains. A study was undertaken to determine the number of MRSA clones responsible for nosocomial infections in France. Strains responsible for nosocomial infections meeting CDC criteria were collected one week every month from June to October 1997 in nine French hospitals. Strains that were positive by the oxacillin-resistance screening test were studied for the IS 431, femA, and mecA genes. Strain type was identified using pulsed-field gel electrophoresis of fragments produced by Smal digestion. Susceptibility to antimicrobials was evaluated based on inhibition zone diameters and minimal inhibitory concentrations determined using the agar dilution method. The 83 strains studied were distributed across four pulsotypes. Eleven resistance phenotypes were identified by ascending hierarchical classification based on inhibition zone diameters. MRSAs responsible for nosocomial infections belong to a limited number of clones that express variable levels of resistance to antimicrobials.